This analysis revealed that CD38 mRNA was more highly expressed in malignant EOC than in borderline tumors, and ovarian endometrioid carcinoma had lower CD38 expression than ovarian serous cancer (Supplementary Figure S1). The gene discussed is CD38; the disease is ovarian endometrioid carcinoma.